Resmed Inc
NYSE:RMD
Intrinsic Value
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. [ Read More ]
The intrinsic value of one RMD stock under the Base Case scenario is 163.79 USD. Compared to the current market price of 178.47 USD, Resmed Inc is Overvalued by 8%.
Valuation Backtest
Resmed Inc
Run backtest to discover the historical profit from buying and selling RMD stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Resmed Inc
Current Assets | 2.4B |
Cash & Short-Term Investments | 210.2m |
Receivables | 764.3m |
Other Current Assets | 1.4B |
Non-Current Assets | 4.5B |
Long-Term Investments | 66.1m |
PP&E | 705.2m |
Intangibles | 3.4B |
Other Non-Current Assets | 365.7m |
Current Liabilities | 764.1m |
Accounts Payable | 202.4m |
Accrued Liabilities | 356.2m |
Other Current Liabilities | 205.5m |
Non-Current Liabilities | 1.7B |
Long-Term Debt | 1.2B |
Other Non-Current Liabilities | 442.4m |
Earnings Waterfall
Resmed Inc
Revenue
|
4.5B
USD
|
Cost of Revenue
|
-2B
USD
|
Gross Profit
|
2.5B
USD
|
Operating Expenses
|
-1.3B
USD
|
Operating Income
|
1.2B
USD
|
Other Expenses
|
-324.8m
USD
|
Net Income
|
890.4m
USD
|
Free Cash Flow Analysis
Resmed Inc
What is Free Cash Flow?
RMD Profitability Score
Profitability Due Diligence
Resmed Inc's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Score
Resmed Inc's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
RMD Solvency Score
Solvency Due Diligence
Resmed Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Resmed Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RMD Price Targets Summary
Resmed Inc
According to Wall Street analysts, the average 1-year price target for RMD is 206.73 USD with a low forecast of 165.64 USD and a high forecast of 238.35 USD.
Ownership
RMD Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
RMD Price
Resmed Inc
Average Annual Return | 24.74% |
Standard Deviation of Annual Returns | 32.26% |
Max Drawdown | -54% |
Market Capitalization | 26.2B USD |
Shares Outstanding | 147 088 992 |
Percentage of Shares Shorted | 6.12% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 7,970 full-time employees. The firm is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep apnea, chronic obstructive pulmonary disease (COPD), neuromuscular disease and other chronic diseases. The firm operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. Sleep apnea includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The firm's portfolio of products includes ventilation devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.
Contact
IPO
Employees
Officers
The intrinsic value of one RMD stock under the Base Case scenario is 163.79 USD.
Compared to the current market price of 178.47 USD, Resmed Inc is Overvalued by 8%.